Skip to content
Semaglutide 10 mg
Metabolic & Weight

Semaglutide

Long-acting GLP-1 receptor agonist.

$75.99
/ 10 mg
Size

This size is currently out of stock.

Volume pricing
2–3
5%
4–6
10%
7–9
15%
10+
20%
US-basedHPLC-verifiedWhy crypto?

Crypto checkout · $15 US shipping, free over $199.

Research use only

For research and laboratory use only. Not for human or veterinary consumption.

99% · by HPLCHow we verify →

About this compound

Semaglutide is a long-acting GLP-1 receptor agonist engineered for sustained, week-spanning stability. By closely mimicking the body's own incretin hormone GLP-1, it engages the glucose-regulating and appetite-signaling pathways at the center of modern metabolic research — making it one of the most studied and influential peptides in the incretin class.

Its extended half-life and steady receptor engagement are what set it apart: research models prize Semaglutide for smooth, durable signaling rather than sharp peaks and troughs. This stability supports consistent glucose-pathway activity, measured gastric emptying, and well-regulated appetite signaling across the full research window.

Supplied as a stable lyophilized powder, Semaglutide is a cornerstone reference compound for metabolic, endocrine, and incretin-signaling investigation. For laboratory and research use only.

Research overview

  1. GLP-1 receptor activation

    Semaglutide selectively engages the GLP-1 receptor, the central node of incretin signaling. This targeted activation drives the downstream cascade that governs insulin response, satiety cues, and glucose handling. In research models, its high receptor affinity makes it a clean, reliable tool for studying GLP-1 pathway biology.

  2. Glucose-pathway regulation

    By amplifying glucose-dependent insulin signaling, Semaglutide supports steadier glucose handling and improved metabolic balance in research settings. Its glucose-dependent mechanism is a key reason it is favored for investigating controlled, physiological glycemic regulation. This makes it a valued probe for endocrine and metabolic studies.

  3. Appetite & satiety signaling

    Semaglutide acts on appetite-regulating circuits, promoting satiety and reducing drive to feed in research models. This appetite-modulating action underpins much of the interest in GLP-1 agonists for body-composition and energy-balance research. Investigators value it for studying the neuro-metabolic links between incretin signaling and feeding behavior.

  4. Gastric emptying & digestion timing

    A hallmark of GLP-1 activity is the slowing of gastric emptying, which extends the sense of fullness and smooths post-meal glucose excursions. Semaglutide reliably engages this mechanism, making it a useful tool for studying the gut-metabolic axis. Its consistent effect on digestion timing supports research into nutrient handling and satiety duration.

  5. Long-acting stability

    Semaglutide's extended half-life delivers sustained receptor engagement across a weekly research window, avoiding the rapid clearance of shorter peptides. This durability supports steady, reproducible signaling — a major advantage for longitudinal metabolic study designs. Its stability profile is central to why it has become a benchmark long-acting GLP-1 reference compound.

Research use only

All products are sold for laboratory and research use only and are not for human or veterinary consumption, diagnosis, or treatment of any kind. These statements have not been evaluated by the U.S. Food and Drug Administration. The products and statements are not intended to diagnose, treat, cure, or prevent any disease. Amino Meta is a chemical supplier and is not a compounding pharmacy or an outsourcing facility as defined under sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act.

Add the essentials

Researcher reviews

No researcher reviews yet — verified buyers can review after ordering.

$75.99
Out of stock